fbpx

Day

oktober 20, 2011
. Collaboration to leverage Syntaxin and Ipsen’s expertise in the discovery and development of botulinum toxins   Paris (France) and Oxford (UK), 20 October 2011 – Ipsen (Euronext: IPN, ADR: IPSEY) and Syntaxin, a biotechnology company specialising in innovative biopharmaceutical therapies targeting cell secretion pathways, announced today a global strategic collaboration to explore the discovery...

Nyheder

Lundbeckfonden
Hjernesygdomme koster samfundet mindst 39 mia. kroner
18. november 2020
Danske forskere leverer beviset: Kejsersnit kan lede til astma og allergi
12. november 2020
En helt ny slags ’antabus’ – men mod kokainmisbrug
10. november 2020

Lundbeckfonden

Lundbeckfonden Ventures

Lundbeckfonden Emerge